Treatment satisfaction and its association with anxiety, depression and fear of COVID-19 among Lebanese inpatients with schizophrenia
| Autor: | Sahar Obeid, Souheil Hallit, Zeinab Bitar, Chadia Haddad |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Multivariate analysis
mesh:Multivariate Analysis patient satisfaction Epidemiologic Factors Cross-sectional study Pharmaceutical Science cross-sectional studies mesh:Risk Factors Pharmacy mesh:Epidemiologic Factors Anxiety inpatients Risk Factors Medicine Psychiatric hospital risk factors mesh:Anxiety Disorders Lebanon Depression (differential diagnoses) Original Research Depression mesh:COVID-19 Fear anxiety Anxiety Disorders mesh:Depression mesh:Patient Satisfaction multivariate analysis mesh:Schizophrenia covid-19 lebanon Schizophrenia Patient Satisfaction depression fear medicine.symptom Clinical psychology RM1-950 Patient satisfaction Pharmacy and materia medica anxiety disorders Rating scale mesh:Anxiety mesh:Inpatients Inpatients business.industry COVID-19 epidemiologic factors medicine.disease schizophrenia RS1-441 mesh:Fear Cross-Sectional Studies mesh:Cross-Sectional Studies mesh:Lebanon Multivariate Analysis Therapeutics. Pharmacology business |
| Zdroj: | Pharmacy Practice Pharmacy Practice (Granada) v.19 n.3 2021 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname Pharmacy Practice, Vol 19, Iss 3, p 2364 (2021) |
| ISSN: | 1885-642X |
| Popis: | Background: The patient's evaluation of treatment and its associated outcomes define the treatment satisfaction. The quality of treatment satisfaction and healthcare service has been affected by depression, anxiety and fear of the current coronavirus disease 2019 (COVID-19) pandemic. Objective: Therefore, this study aimed to assess factors associated with treatment satisfaction among Lebanese inpatients with schizophrenia, namely depression, anxiety and fear of COVID-19. Methods: A cross-sectional study was conducted between September and November 2020, enrolled 118 patients with chronic schizophrenia consecutively admitted to Psychiatric Hospital of the Cross, Lebanon. The Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Satisfaction Scale (FACIT-TS-PS) was used to assess treatment satisfaction, the Lebanese Anxiety Scale -10 (LAS-10) was used to assess anxiety, Montgomery-Asberg Depression Rating Scale (MADRS) to assess depression and the Fear of COVID-19 Scale to assess the level of fear of the COVID-19 pandemic. Results: The mean scores of the scales were as follows: treatment satisfaction (65.20; SD 16.11; median=71), LAS-10 (13.65; SD 6.02), MADRS (9.09; SD 6.69) and fear of COVID-19 (18.59; SD 6.78). Higher depression (r= -0.46, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|